| Assay ID | Title | Year | Journal | Article |
|---|
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1347098 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347090 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1347425 | Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347105 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347091 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1347108 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347089 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347106 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347107 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347104 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347093 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347095 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347407 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7
| High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
| AID1347102 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347092 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347424 | RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347097 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347094 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347099 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347100 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347101 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347096 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347103 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID447004 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 30 mg/kg, ip after 2 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447158 | Anticonvulsant activity against kindle motor-induced seizure in rat assessed as after discharge duration at 100 mg/kg, ip after 75 mins by hippocampal kindling screen test | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447151 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 100 mg/kg, ip after 0.25 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID446996 | Anticonvulsant activity in Sprague-Dawley rat assessed as inhibition of maximal electric shock-induced seizure at 30 mg/kg, po after 0.25 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID115844 | Compound was tested for the number of control mice with decreased RBC to that of number of tested mice at 100 mg/kg p.o.; 8/8 | 1998 | Bioorganic & medicinal chemistry letters, Jan-06, Volume: 8, Issue:1
| Discovery of FR115092: a novel antinephritic agent. |
| AID447147 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 80 mg/kg, ip after 0.5 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447161 | Anticonvulsant activity against kindle motor-induced seizure in rat assessed as after discharge duration at 100 mg/kg, ip after 165 mins by hippocampal kindling screen test | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID446998 | Anticonvulsant activity in Sprague-Dawley rat assessed as inhibition of maximal electric shock-induced seizure at 30 mg/kg, po after 1 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID446992 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of maximal electric shock-induced seizure at 300 mg/kg, ip after 0.5 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID446997 | Anticonvulsant activity in Sprague-Dawley rat assessed as inhibition of maximal electric shock-induced seizure at 30 mg/kg, po after 0.5 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447152 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 100 mg/kg, ip after 0.5 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447001 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 30 mg/kg, ip after 0.25 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447149 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 80 mg/kg, ip after 2 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID446995 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of maximal electric shock-induced seizure at 300 mg/kg, ip after 4 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447146 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 80 mg/kg, ip after 0.25 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID446993 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of maximal electric shock-induced seizure at 30 mg/kg, ip after 4 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447159 | Anticonvulsant activity against kindle motor-induced seizure in rat assessed as after discharge duration at 100 mg/kg, ip after 105 mins by hippocampal kindling screen test | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447156 | Anticonvulsant activity against kindle motor-induced seizure in rat assessed as after discharge duration at 100 mg/kg, ip after 15 mins by hippocampal kindling screen test | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID446991 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of maximal electric shock-induced seizure at 100 mg/kg, ip after 0.5 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447164 | Anticonvulsant activity against kindle motor-induced seizure in rat assessed as after discharge duration at 100 mg/kg, ip after 255 mins by hippocampal kindling screen test | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID1653410 | Anti-leprotic activity against Mycobacterium leprae infected in BALB/c mouse assessed as time delay in bacterial multiplication in footpad at 0.0087 g/100g of diet administered via feed starting 60 or 75 day post infection up to 90 days by Shepard's kinet | 2019 | Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
| Insights of synthetic analogues of anti-leprosy agents. |
| AID446994 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of maximal electric shock-induced seizure at 100 mg/kg, ip after 4 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447157 | Anticonvulsant activity against kindle motor-induced seizure in rat assessed as after discharge duration at 100 mg/kg, ip after 45 mins by hippocampal kindling screen test | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID117036 | Inhibition of proteinuria in the graft-versus-host disease mice following 100 mg/kg p.o. administration. | 1998 | Bioorganic & medicinal chemistry letters, Jan-06, Volume: 8, Issue:1
| Discovery of FR115092: a novel antinephritic agent. |
| AID447163 | Anticonvulsant activity against kindle motor-induced seizure in rat assessed as after discharge duration at 100 mg/kg, ip after 225 mins by hippocampal kindling screen test | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447155 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 100 mg/kg, ip after 4 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447162 | Anticonvulsant activity against kindle motor-induced seizure in rat assessed as after discharge duration at 100 mg/kg, ip after 195 mins by hippocampal kindling screen test | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447002 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 30 mg/kg, ip after 0.5 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID446999 | Anticonvulsant activity in Sprague-Dawley rat assessed as inhibition of maximal electric shock-induced seizure at 30 mg/kg, po after 2 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447153 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 100 mg/kg, ip after 1 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447154 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 100 mg/kg, ip after 2 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447003 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 30 mg/kg, ip after 1 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447148 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 80 mg/kg, ip after 1 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447160 | Anticonvulsant activity against kindle motor-induced seizure in rat assessed as after discharge duration at 100 mg/kg, ip after 135 mins by hippocampal kindling screen test | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID433903 | Hepatotoxicity in mouse assessed as carcinogenic potency | 2009 | European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
| Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals. |
| AID447005 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 30 mg/kg, ip after 4 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447150 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of minimal clonic seizure at 80 mg/kg, ip after 4 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447006 | Neurotoxicity in CF1 albino mouse at 300 mg/kg, ip by rotarod test after 4 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID446990 | Anticonvulsant activity in CF1 albino mouse assessed as inhibition of maximal electric shock-induced seizure at 30 mg/kg, ip after 0.5 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID447000 | Anticonvulsant activity in Sprague-Dawley rat assessed as inhibition of maximal electric shock-induced seizure at 30 mg/kg, po after 4 hrs | 2009 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
| In vivo evaluation of diaminodiphenyls: anticonvulsant agents with minimal acute neurotoxicity. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3
| High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |